Xalatan and Cataract - a phase IV clinical study of FDA data

Summary:

Cataract is found among people who take Xalatan, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Xalatan and have Cataract. It is created by eHealthMe based on reports of 24,358 people who have side effects when taking Xalatan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jul, 31, 2023

24,358 people reported to have side effects when taking Xalatan.
Among them, 1,359 people (5.58%) have Cataract.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 24,707 Xalatan users for its effectiveness, alternative drugs and more.

What is Cataract?

Cataract (clouding of the lens inside the eye) is found to be associated with 2,798 drugs and 2,076 conditions by eHealthMe.

Number of Xalatan and Cataract reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Xalatan and have Cataract?

Check whether Cataract is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .

Related studies

How severe was Cataract and when was it recovered:

Cataract in Xalatan

Expand to all the drugs that have ingredients of latanoprost:

Cataract and drugs with ingredients of latanoprost (1,617 reports)

Alternative drugs to, pros and cons of Xalatan:

Xalatan (24,707 reports)

Common Xalatan side effects:

Browse all side effects of Xalatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Cataract treatments and more:

Cataract (59,335 reports)

COVID vaccines that are related to Cataract:

Common drugs associated with Cataract:

All the drugs that are associated with Cataract:

Cataract (2,798 drugs)

Common conditions associated with Cataract:

Rheumatoid arthritis: 7,345 reports
High blood pressure: 4,160 reports
Osteoporosis: 3,609 reports
Diabetes: 2,774 reports
Type 2 diabetes: 2,697 reports

All the conditions that are associated with Cataract:

Cataract (2,076 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Xalatan) and Xalatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.